Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Paragon 28, Inc. stock logo
FNA
Paragon 28
$13.11
+0.1%
$13.08
$4.65
$13.13
$1.10B1.471.13 million shs19.38 million shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$5.53
+7.8%
$5.02
$3.75
$11.00
$319.52M1.991.75 million shs1.40 million shs
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$17.10
+4.8%
$16.85
$9.70
$25.00
$1.10B1.63186,826 shs158,354 shs
SSII
SS Innovations International
$6.00
$0.00
$0.32
$22.42
$1.16BN/A34,877 shs48,205 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.00%0.00%0.00%+0.61%+74.50%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-2.10%-2.29%+4.06%-15.07%-38.42%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
-7.06%-8.52%-1.39%-6.04%+19.04%
SSII
SS Innovations International
+6.01%-0.50%+599,999,900.00%+599,999,900.00%+599,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/AN/AN/AN/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
1.5759 of 5 stars
3.53.00.00.00.60.00.6
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
1.0503 of 5 stars
0.00.00.04.22.73.30.0
SSII
SS Innovations International
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Paragon 28, Inc. stock logo
FNA
Paragon 28
2.20
Hold$12.75-2.71% Downside
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
3.00
Buy$9.5071.79% Upside
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
0.00
N/AN/AN/A
SSII
SS Innovations International
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest NNOX, SSII, PLSE, and FNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/6/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
5/23/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $10.00
5/22/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/17/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
4/1/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$12.00 ➝ $9.00
3/31/2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
(Data available from 6/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Paragon 28, Inc. stock logo
FNA
Paragon 28
$256.18M4.29N/AN/A$2.05 per share6.39
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$11.55M27.68N/AN/A$3.55 per share1.56
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$700K1,643.41N/AN/A$0.81 per share21.11
SSII
SS Innovations International
$22.13M52.49N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$57.53M-$0.63N/AN/AN/A-25.31%-37.90%-18.22%N/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$60.78M-$0.90N/AN/AN/A-465.38%-27.63%-24.72%8/19/2025 (Estimated)
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
-$42.21MN/A0.00N/AN/A-96.89%-74.83%8/11/2025 (Estimated)
SSII
SS Innovations International
N/AN/A0.00N/AN/AN/AN/AN/A

Latest NNOX, SSII, PLSE, and FNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/22/2025Q1 2025
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$0.23-$0.21+$0.02-$0.21$3.98 million$3.00 million
5/8/2025Q1 2025
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/A-$0.25N/A-$0.25N/AN/A
3/31/2025Q4 2024
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$0.15-$0.23-$0.08-$0.23$3.80 million$3.00 million
3/6/2025Q4 2024
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$0.12-$0.13-$0.01-$0.13$70.81 million$71.75 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
SSII
SS Innovations International
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.79
3.50
1.60
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/A
4.64
4.56
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/A
11.93
11.93
SSII
SS Innovations International
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Paragon 28, Inc. stock logo
FNA
Paragon 28
63.57%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
21.49%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
76.95%
SSII
SS Innovations International
N/A

Insider Ownership

CompanyInsider Ownership
Paragon 28, Inc. stock logo
FNA
Paragon 28
15.32%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
7.74%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
71.50%
SSII
SS Innovations International
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Paragon 28, Inc. stock logo
FNA
Paragon 28
343,00083.94 million70.89 millionOptionable
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
19057.78 million53.31 millionOptionable
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
14067.27 million17.53 millionOptionable
SSII
SS Innovations International
4193.60 millionN/AN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Paragon 28 stock logo

Paragon 28 NYSE:FNA

$13.10 +0.02 (+0.11%)
Closing price 04/17/2025
Extended Trading
$13.10 0.00 (0.00%)
As of 04/17/2025 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Nano-X Imaging stock logo

Nano-X Imaging NASDAQ:NNOX

$5.53 +0.40 (+7.80%)
Closing price 04:00 PM Eastern
Extended Trading
$5.48 -0.06 (-0.99%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Pulse Biosciences stock logo

Pulse Biosciences NASDAQ:PLSE

$17.10 +0.78 (+4.78%)
Closing price 04:00 PM Eastern
Extended Trading
$17.08 -0.02 (-0.12%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

SS Innovations International NASDAQ:SSII

$6.00 0.00 (0.00%)
As of 04:00 PM Eastern

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.